Pharmacogenomics and Polypharmacy: Why Reporting Speed Matters
Polypharmacy isn’t rare. For many older adults, and especially within Veteran populations, it’s the norm.
Managing multiple medications across multiple prescribers is already complex. Add pharmacogenomics, and the value is clear – but only if the timing works. A PGx result that arrives after the prescription doesn’t help. One that comes before it? That’s a decision-making asset.
If your team is supporting complex patients with evolving med lists, here’s why fast, consistent PGx reporting matters more than ever.
Every Delay Is a Missed Opportunity
PGx insights can inform drug selection, dosage, and risk – but only if they’re available at the point of prescribing.
If your reporting process takes days or weeks you will lose the clinical moment. Medications are already filled. Alternatives aren’t considered. The value of testing drops.
Polypharmacy Patients Need Fast Stratification
Most PGx panels don’t test for one drug, they test for dozens. But polypharmacy patients aren’t asking about future prescriptions. They’re already on a cocktail.
Clinicians need:
- Gene-drug interactions flagged by relevance
- Risk stratification by urgency or priority
- Summaries they can use in time-limited settings
Slow, unstructured reports make this harder. However, fast, templated reports make it possible.
Why Speed Doesn’t Mean Sacrificing Quality
Some labs worry that faster reporting equals a less thorough review. But with the right tools, automation enhances quality by enforcing consistency, applying versioned logic, and removing manual formatting.
Speed doesn’t require compromise – especially when automation enforces consistency, eliminates unnecessary steps, and keeps the focus on clinical utility.
How PraediGene Helps
PraediGene is purpose-built for clinical-grade PGx reporting in high-complexity populations. It delivers:
- Rapid turnaround from FASTQ to final report
- Built-in support for PharmWatch variant interpretation
- Gene-drug summaries structured for pharmacist and provider review
- Report templates tailored to polypharmacy and geriatric settings
- EHR-compatible outputs that support CDS integration
Used across VA sites serving older adult populations, PraediGene delivers the speed, clarity, and auditability needed to scale PGx responsibly.
PraediGene supports fast, structured PGx reporting in complex care environments.
In polypharmacy populations, the question isn’t whether PGx helps. It’s whether the insights show up in time to matter. Rapid PGx reporting isn’t a technical feature. It’s a clinical requirement.